American researcher Phyllis Arthur warns of a growing global health crisis that threatens millions of lives due to bacterial infections' resistance to antibiotics. A scientific report predicts that this crisis could contribute to the deaths of approximately 170 million people over the next 25 years.
Arthur explained in her article published on the American Hill website that antibiotic resistance has become a significant challenge, with estimates suggesting that one in every 6 bacterial infections has become resistant to conventional antibiotic treatments. This phenomenon complicates the treatment of many infectious diseases, opening the door to greater health disasters in the future.
Details of the Situation
Reports indicate that developing new antibiotics is the only solution to confront this crisis; however, this research faces several challenges. In 2024, efforts were underway to develop new antibiotics, but only five out of 90 were effective against pathogens classified by the World Health Organization as "critically important."
The reasons for the lack of innovation stem from the economic constraints faced by pharmaceutical companies in developing new antibiotics, as these companies struggle to achieve real profits from their sales. Experts point out that the overuse of conventional antibiotics has led to increased bacterial resistance, as microbes adapt to the drugs over time.
Background & Context
Studies indicate that drug-resistant bacteria currently cause the deaths of more than 1 million people annually worldwide. Estimates show that developing a single antibiotic can take more than 10 years and cost over $1 billion, while sales revenues can be negative by as much as $50 million.
As a result of these conditions, major companies have withdrawn from the antibiotic development market, while smaller companies continue to struggle to survive. This situation raises concerns about the future of public health, as the lack of innovation in this field could lead to a greater outbreak of infectious diseases.
Impact & Consequences
If urgent action is not taken, antibiotic resistance could have dire consequences for public health, including increased mortality and morbidity rates. This crisis may also impact health systems worldwide, increasing the financial burden on countries.
Addressing this crisis requires international cooperation and the development of effective strategies to enhance research and innovation in the field of antibiotics. There must be government and private investments to support the development of new drugs, in addition to improving the use of existing antibiotics.
Regional Significance
In the Arab region, the crisis may be more acute due to the weak health systems in some countries, making them susceptible to disease outbreaks. Arab countries need to strengthen their health capabilities and invest in scientific research to face these challenges.
This issue serves as a warning to all nations, as antibiotic resistance knows no borders and could affect everyone without exception. A comprehensive response is necessary to tackle this global health crisis.